Dabomb Protein (6578) — Cash Flow Reinvestment Rate
Dabomb Protein (6578) has a Cash Flow Reinvestment Rate of 3.69x as of March 2025, reinvesting NT$29.94 Million (capex NT$20.59 Million plus investments NT$9.35 Million) from operating cash flow of NT$8.12 Million. Explore 6578 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dabomb Protein Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Dabomb Protein across 10 annual periods. Also explore 6578 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Dabomb Protein (2015–2025)
Year-by-year capital reinvestment analysis for Dabomb Protein. For live market cap and broader valuation context, see Dabomb Protein stock valuation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.64x | NT$60.61 Million | NT$16.65 Million | NT$37.69 Million | ▲ +435.7% |
| 2024 | 0.68x | NT$32.32 Million | NT$47.55 Million | NT$30.32 Million | ▼ -91.3% |
| 2023 | 7.80x | NT$50.77 Million | NT$6.51 Million | NT$18.87 Million | ▲ +189.9% |
| 2022 | 2.69x | NT$53.05 Million | NT$19.71 Million | NT$20.16 Million | ▼ -43.4% |
| 2020 | 4.76x | NT$63.80 Million | NT$13.41 Million | NT$18.31 Million | ▲ +69.4% |
| 2019 | 2.81x | NT$93.39 Million | NT$33.26 Million | NT$91.81 Million | ▼ -62.4% |
| 2018 | 7.46x | NT$164.65 Million | NT$22.07 Million | NT$163.06 Million | ▲ +94.3% |
| 2017 | 3.84x | NT$168.40 Million | NT$43.87 Million | NT$166.46 Million | ▲ +27.2% |
| 2016 | 3.02x | NT$179.88 Million | NT$59.58 Million | NT$92.71 Million | ▲ +7354.3% |
| 2015 | 0.04x | NT$5.66 Million | NT$139.78 Million | NT$5.33 Million | — |